Helicobacter

Article	Citations
The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta‐analysis	60
PPI‐amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta‐analysis	53
Review: Epidemiology of Helicobacter pylori	46
Review: Extragastric diseases andHelicobacter pylori	40
A comparative study of 14‐day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first‐line Helicobacter pylori infection eradication: A randomized	38
A meta‐analysis of the association between Helicobacter pylori infection and risk of atherosclerotic cardiovascular disease	38
The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults	37
Review: Pathogenesis of Helicobacter pylori infection	37
Review: Diagnosis of Helicobacter pylori infection	33
Time trends and other sources of variation in Helicobacter pylori infection in mainland China: A systematic review and meta‐analysis	33
PCR analysis and specific immunohistochemistry revealing a high prevalence of non‐Helicobacter pylori Helicobacters in Helicobacter pylori‐negative gastric disease patients in Japan: Hig	32
Review – Treatment of Helicobacter pylori infection 2020	32
Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta‐analysis	32
Helicobacter pylori induced reactive oxygen Species: A new and developing platform for detection	29
Effects of non‐viableLactobacillus reutericombining with 14‐day standard triple therapy onHelicobacter pylorieradication: A randomized double‐blind placebo‐controlled trial	28
Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study	27
Helicobacter pylorifirst‐line and rescue treatments in patients allergic to penicillin: Experience from the European Registry onH pylorimanagement (Hp‐EuReg)	26
Effect of probiotics during vonoprazan‐containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial	26
Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma	26
PPI‐amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta‐analysis	24
Helicobacter pylori “Test‐and‐Treat” strategy with urea breath test: A cost‐effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain—Results of	24
The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta‐analysis	22
Re‐assessment of the disk diffusion technique for routine antimicrobial susceptibility testing for Helicobacter pylori	22
Evaluation of the Allplex™ H pylori and ClariR PCR Assay for Helicobacter pylori detection on gastric biopsies	22
Gastric microbiota and Helicobacter pylori in Indonesian population	22

Long‐term changes in the gut microbiota after 14‐day bismuth quadruple therapy in penicillin‐allergic children	21
An overview of traditional Chinese medicine therapy for Helicobacter pylori–related gastritis	21
Helicobacter pylori infection and eradication: Exploring their impacts on the gastrointestinal microbiota	20
Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan	20
A panel of stomach‐specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area	20
Impact of smoking on the eradication of Helicobacter pylori	20
Non‐bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real‐life study	20
Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux	20
Efficacy and safety of a new rifabutin‐based triple therapy with vonoprazan for refractoryHelicobacter pyloriinfection: A prospective single‐arm study	20
Efficacy of eradication therapy in Helicobacter pylori‐negative gastric mucosa‐associated lymphoid tissue lymphoma: A meta‐analysis	19
Impact of body size on first‐line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy	19
Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice	19
The appropriate cutoff gastric pH value for Helicobacter pylori eradication with bismuth‐based quadruple therapy	18
CRISPR‐based detection of Helicobacter pylori in stool samples	18
Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta‐analysis	18
Awareness and attitudes regarding Helicobacter pylori infection in Chinese physicians and public population: A national cross‐sectional survey	18
Advantage of 16S rRNA amplicon sequencing in Helicobacter pylori diagnosis	18
Need for standardization and harmonization of Helicobacter pylori antimicrobial susceptibility testing	17
Helicobacter pylori induces gastric cancer via down‐regulating miR‐375 to inhibit dendritic cell maturation	17
The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota—a double‐blind, placebo‐controlled, randomiz	17
Triple‐nanostructuring‐based noninvasive electro‐immune sensing of CagA toxin for Helicobacter pylori detection	17
Transmission of Helicobacter pylori between a human and two dogs: A case report	16
Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota	16
Helicobacter pylori infection and the progression of atherosclerosis: A systematic review and meta‑analysis	15
Helicobacter pylori infection is associated with the co‐occurrence of bacteria in the oral cavity and the gastric mucosa	15
Helicobacter pylori test‐and‐treat strategy for second‐year junior high school students aimed at the prevention of gastric cancer in Takatsuki City	15
Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the European Hel	15
Prevalence and risk factors of Helicobacter pylori infection in Wuwei, a high‐risk area for gastric cancer in northwest China: An all‐ages population‐based cross‐sectional study	15
Effects of sodium butyrate supplementation on inflammation, gut microbiota, and short‐chain fatty acids in Helicobacter pylori‐infected mice	15
Rabeprazole‐amoxicillin dual therapy as first‐line treatment for H pylori eradication in special patients: A retrospective, real‐life study	15
Survey of the antimicrobial resistance of Helicobacter pylori in France in 2018 and evolution during the previous 5 years	15
Review: Other Helicobacter species	15
10‐Day and 14‐day high‐dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis	14
Eradication rate and safety of a “simplified rescue therapy”: 14‐day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in	14
Association between bacteria other than Helicobacter pylori and the risk of gastric cancer	14
Association between Helicobacter pylori infection and growth outcomes in children: A meta‐analysis	14
Application of WeChat platform in the management of patients infected with Helicobacter pylori	14
Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in China	14
Diagnosis and treatment of Helicobacter pylori infection by physicians in China: A nationwide cross‐sectional study	14
Whole family—based Helicobacter pylori eradication is a superior strategy to single‐infected patient treatment approach: A systematic review and meta‐analysis	14
Influence of Helicobacter pylori infection on PD‐1/PD‐L1 blockade therapy needs more attention	14
Helicobacter pylori and the intestinal microbiome among healthy school‐age children	14
Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections—Exploratory study	14
Helicobacter pylori infection in children with celiac disease: Multi‐center, cross‐sectional study	13
Review: Helicobacter pylori infection in children	13
Searching for an optimal therapy for H pylori eradication: High‐dose proton‐pump inhibitor dual therapy with amoxicillin vs. standard triple therapy for 14 days	13
The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing	13
Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala	13
Immune evaluation of aSaccharomyces cerevisiae‐based oral vaccine againstHelicobacter pyloriin mice	13
Helicobacter pylori adhesins: HpaA a potential antigen in experimental vaccines for H. pylori	12

The recurrence rate ofHelicobacter pyloriin recent 10 years: A systematic review and meta‐analysis	12
Susceptibility‐guided therapy for Helicobacter pylori‐infected penicillin‐allergic patients: A prospective clinical trial of first‐line and rescue therapies	12
Association betweenHelicobacter pyloriantibodies determined by multiplex serology and gastric cancer risk: A meta‐analysis	12
Pepsinogen II in gastritis and Helicobacter pylori infection	12
Eradication of Helicobacter pylori infection decreases risk for dyslipidemia: A cohort study	12
Prevalence, clinical features, and esophagogastroduodenoscopy (EGD) findings of non‐Helicobacter pylori Helicobacter infection: A study of 50 cases at a single facility in Japan	12
Long term impact of vonoprazan‐based Helicobacter pylori treatment on gut microbiota and its relation to post‐treatment body weight changes	12
Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions	12
Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost‐effectiveness analysis	11
Extracellular vesicles from helicobacter pylori‐infected cells and helicobacter pylori outer membrane vesicles in atherosclerosis	11
Adherence to Maastricht V/Florence consensus report for the management ofHelicobacter pyloriinfection among primary care physicians and medical students in Croatia: A cross‐sectional study	11
Effect of enhanced patient instructions onHelicobacter pylorieradication: A systematic review and meta‐analysis of randomized controlled trials	10
Tetracycline‐levofloxacin versus amoxicillin‐levofloxacin quadruple therapies in the second‐line treatment of Helicobacter pylori infection	10
Application of molecular techniques inHelicobacter pyloridetection: limitations and improvements	10
Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial	10
Gastric organoids: Advancing the study of H. pylori pathogenesis and inflammation	10
Dendritic cell‐derived TGF‐β mediates the induction of mucosal regulatory T‐cell response to Helicobacter infection essential for maintenance of immune tolerance in mice	10
Helicobacter pylori infection modulates endogenous hydrogen sulfide production in gastric cancer AGS cells	9
Transmission routes and patterns of helicobacter pylori	9
Review ‐ Helicobacter pylori and non‐malignant upper gastro‐intestinal diseases	9
Unraveling antimicrobial resistance in Helicobacter pylori: Global resistome meets global phylogeny	9
Doxycycline and minocycline inHelicobacter pyloritreatment: A systematic review and meta‐analysis	9
Long noncoding RNA NEAT1 promotes tumorigenesis in H. pylori gastric cancer by sponging miR‐30a to regulate COX‐2/BCL9 pathway	9
Quadruple therapy with vonoprazan 20 mg daily as a first‐line treatment for Helicobacter pylori infection: A single‐center, open‐label, noninferiority, randomized controlled trial	9
Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers	9
Rabeprazole plus amoxicillin dual therapy is equally effective to bismuth‐containing quadruple therapy for Helicobacter pylori eradication in central China: A single‐center, prospective, open‐l	9
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea	9
Helicobacter pylori infection and risk of cardiovascular disease	9
Long‐term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children	9
Integrative proteomic and metabolomic analyses reveal the mechanism by which bismuth enables Helicobacter pylori eradication	9
CRHP Finder, a webtool for the detection of clarithromycin resistance in Helicobacter pylori from whole‐genome sequencing data	9
Efficacy and safety of bismuth‐based quadruple therapy forHelicobacterpylorieradication in children	9
Annual eradication rate of bismuth‐containing quadruple therapy as second‐line treatment forHelicobacter pyloriinfection: A 15‐year prospective study at a tertiary hospital in Korea	9
Helicobacter pylori knowledge and perception among multi‐ethnic Asians	8
Declining trends of prevalence ofHelicobacter pyloriinfection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis	8
Cardia and non‐cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta‐analysis, and estimation of population attributable fraction	8
Lack of association between Helicobacter pylori infection and childhood overweight/obesity	8
Comparison of clinical outcomes and FOXP3, IL‐17A responses in Helicobacter pylori infection in children versus adults	8
Persistent infection of Helicobacter pylori affects weight loss in obese population compared with persistent negative: A case‐control study based on healthy Chinese	8
Consistency of Helicobacter pylori eradication rates of first‐line concomitant and sequential therapies in Korea: A nationwide multicenter retrospective study for the last 10 years	8
Helicobacter pylori infection and risk of multiple sclerosis: An updated meta‐analysis	8
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study	8
Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost‐effectiveness analysis	8
Dynamic changes in antibiotic resistance genes and gut microbiota after Helicobacter pylori eradication therapies	8
Efficacy of bismuth‐based quadruple therapy for eradication of Helicobacter pylori infection based on previous antibiotic exposure: A large‐scale prospective, single‐center clinical trial in Ch	8
A comparative whole genome analysis of Helicobacter pylori from a human dense South Asian setting	8
AI‐2 represses CagA expression and bacterial adhesion, attenuating the Helicobacter pylori‐induced inflammatory response of gastric epithelial cells	8
Cholesterol glucosylation–based survival strategy in Helicobacter pylori	8
Helicobacter pylori seroprevalence in six different ethnic groups living in Amsterdam: The HELIUS study	8
Clinical and economic impact of “triple therapy” for Helicobacter pylori eradication on peptic ulcer disease in Australia	8
Investigation of endoscopic findings in nine cases of Helicobacter suis‐infected gastritis complicated by gastric mucosa‐associated lymphoid tissue lymphoma	8
Helicobacter pylori and cardiovascular risk: Only a dead Helicobacter is a good Helicobacter?	7
Upregulation of oncogene Activin A receptor type I by Helicobacter pylori infection promotes gastric intestinal metaplasia via regulating CDX2	7
Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐lineHelicobacter pylorieradication regimen	7
Helicobacter pylori release from yeast as a vesicle‐encased or free bacterium	7
Efficacy of a novel sequential treatment regimen containing bismuth forHelicobacter pylorieradication in Turkish children	7
Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: A multicenter prospective cohort study	7
Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines	7
The relation between Helicobacter pylori immunoglobulin G seropositivity and leukocyte telomere length in US adults from NHANES 1999‐2000	7
Autoimmune atrophic gastritis: The role of Helicobacter pylori infection in children	7
Activation of Aquaporin 5 by carcinogenic Helicobacter pylori infection promotes epithelial‐mesenchymal transition via the MEK/ERK pathway	7
Research Trends on Clinical Helicobacter pylori Eradication: A Bibliometric Analysis from 1983 to 2020	7
Influences ofHelicobacter pyloriinfection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer development	7
Review ‐ Helicobacter, inflammation, immunology and vaccines	7
Persistent advanced periductal fibrosis is associated with cagA‐positive Helicobacter pylori infection in post‐praziquantel treatment of opisthorchiasis	7
“True” Helicobacter pylori infection and non‐cardia gastric cancer: A pooled analysis within the Stomach Cancer Pooling (StoP) Project	7
CagA+Helicobacter pylori infection and N‐nitrosodimethylamine administration induce cholangiocarcinoma development in hamsters	7
Efficacy of bismuth added to standard triple therapy as the first‐line eradication regimen for Helicobacter pylori infection	7
Heat‐killed Helicobacter pylori upregulates NKG2D ligands expression on gastric adenocarcinoma cells via Toll‐like receptor 4	7
Exploration of the molecular mechanisms underlying the antibiotic resistance of Helicobacter pylori: A whole‐genome sequencing‐based study in Southern China	7
Does technology‐enhanced communication improve Helicobacter pylori eradication outcomes?—A meta‐analysis	7
Review: Prevention and management of gastric cancer	7
Duodenal microbiome in patients with or without Helicobacter pylori infection	7
Helicobacter pylori treatment knowledge, access and barriers: A cross‐sectional study	6
Optimized dual therapy for treatment‐naive patients of Helicobacter pylori infection: A large‐scale prospective, multicenter, open‐label, randomized controlled study	6
Lack of significant differences between gastrointestinal tract microbial population structure of Helicobacter pylori‐infected subjects before and 2 years after a single eradication event	6
YouTube as a source of information on Helicobacter pylori: Content and quality analysis	6
Clinicopathological features of nodular gastritis in three classes of age	6
Age of eradication and failure rates of clarithromycin‐containing triple therapy forHelicobacter pylori: A 15‐year population‐based study	6
Both family‐based Helicobacter pylori infection control and management strategy and screen‐and‐treat strategy are cost‐effective for gastric cancer prevention	6

An American lineage of Helicobacter pylori prophages found in Colombia	6
TikTok and Bilibili as sources of information on Helicobacter pylori in China: A content and quality analysis	6
Clinical evaluation of a novel molecular diagnosis kit for detecting Helicobacter pylori and clarithromycin‐resistant using intragastric fluid	6
Favorable outcomes of rescue second‐ or third‐line culture‐based Helicobacter pylori eradication treatment in areas of high antimicrobial resistance	6
Adaptation of an in‐house PCR for the detection of Helicobacter pylori and the mutations associated with macrolide resistance into ready‐to‐use PCR microwell strips	6
Dietary multivalent anti‐Helicobacter pylori immunoglobulin Y significantly increase the H. pylori eradication and improve the clinical symptoms in patients	5
Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori	5
Classification system forHelicobacter pyloritherapies: Compared and contrasted to traditional infectious disease therapy	5
Increased risk of short‐term depressive disorder after Helicobacterpylori eradication: A population‐based nested cohort study	5
Sex differences betweenHelicobacter pyloriinfection and cholesterol levels in an adult health checkup program	5
Risk factors for recurrence of Helicobacter pylori infection after successful eradication in Chinese children: A prospective, nested case‐control study	5
Saccharomyces boulardii CNCM I‐745 supplementation modifies the fecal resistome during Helicobacter pylori eradication therapy	5
New regimens as first‐line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial	5
Quantitative PCR of string‐test collected gastric material: A feasible approach to detect Helicobacter pylori and its resistance against clarithromycin and levofloxacin for susceptib	5
The increasing antimicrobial resistance of Helicobacter pylori in Iran: A systematic review and meta‐analysis	5
Virulence assessment of enterohepaticHelicobacterspecies carried by dogs using the wax moth larvaeGalleria mellonellaas infection model	5
Helicobacter pylori‐positive chronic atrophic gastritis and cellular senescence	5
Helicobacterspecies binding to the human gastric mucosa	5
Effect of Helicobacter pylori eradication therapy on clinical and laboratory biomarkers associated with gastric damage in healthy school‐aged children: A randomized non‐blinded trial	5
The role of Helicobacter pylori in vitamin‐B12 deficiency due to metformin use	5
Effect of Helicobacter pylori eradication on hyperplastic gastric polyps: A systematic review and meta‐analysis	5
Antibiotic resistance patterns of Helicobacter pylori in North Israel – A six‐year study	5
Perspectives from recent advances of Helicobacter pylori vaccines research	5
Antimicrobial resistance of Helicobacter pylori in an eastern German region	5
Effect ofHelicobacter pylorion immunotherapy is gaining more attention	5
Lessons learned from upper gastrointestinal endoscopy in asymptomatic Chinese	4
Dialogue between gastrointestinal tract and skin: New insights into the Helicobacter pylori and atopic dermatitis	4
Pilot studies of vonoprazan‐containing Helicobacter pylori eradication therapy suggest Thailand may be more similar to the US than Japan	4
Discussion on the common controversies of Helicobacter pylori infection	4
Eradication therapy for Helicobacter pylori infection based on the antimicrobial susceptibility test in children: A single‐center study over 12 years	4
Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: A systematic review and meta‐analysis	4
Reinforced medication adherence improvesHelicobacter pylorieradication rate in developing countries: A systematic review and meta‐analysis of randomized controlled trials	4
The outward shift of clarithromycin binding to the ribosome in mutant Helicobacter pylori strains	4
Atrophic gastritis in Helicobacter pylori‐infected children	4
Evaluation of guidelines for diagnosis and treatment of Helicobacter pylori infection	4
Efficacy and safety of vonoprazan‐based dual therapy and esomeprazole‐based dual therapy in eradicating primary Helicobacter pylori infection: A propensity score matching analysis	4
Glycosyltransferase Jhp0106 (PseE) contributes to flagellin maturation in Helicobacterpylori	4
Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow‐up of 51 months	4
Designing strategies for eradication of Helicobacter pylori based on prevalence patterns of infection and antibiotic resistance in a low‐income, medically underserved community in the United St	4
Prevalence of Helicobacter pylori infection among resettled refugees presenting to a family medicine clinic in the United States	4
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia	4
Long‐term improvement in constipation‐related symptoms after Helicobacter pylori eradication therapy	4
Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy	4
A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy o	4
Efficacy of tegoprazan‐based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: A randomized, double‐blind, active‐controlled study	4
Reverse hybrid therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis	4